首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
Authors:Miguel W Tregnaghi  Xavier Sáez-Llorens  Pio López  Hector Abate  Enrique Smith  Adriana Pósleman  Arlene Calvo  Digna Wong  Carlos Cortes-Barbosa  Ana Ceballos  Marcelo Tregnaghi  Alexandra Sierra  Mirna Rodriguez  Marisol Troiti?o  Carlos Carabajal  Andrea Falaschi  Ana Leandro  Maria Mercedes Castrejón  Alejandro Lepetic  Patricia Lommel  William P Hausdorff  Dorota Borys  Javier Ruiz Gui?azú  Eduardo Ortega-Barría  Juan P Yarzábal  Lode Schuerman  on behalf of the COMPAS Group
Institution:Miguel W. Tregnaghi,Xavier Sáez-Llorens,Pio López,Hector Abate,Enrique Smith,Adriana Pósleman,Arlene Calvo,Digna Wong,Carlos Cortes-Barbosa,Ana Ceballos,Marcelo Tregnaghi,Alexandra Sierra,Mirna Rodriguez,Marisol Troiti?o,Carlos Carabajal,Andrea Falaschi,Ana Leandro,Maria Mercedes Castrejón,Alejandro Lepetic,Patricia Lommel,William P. Hausdorff,Dorota Borys,Javier Ruiz Gui?azú, Eduardo Ortega-Barría,Juan P. Yarzábal,Lode Schuerman,on behalf of the COMPAS Group
Abstract:BackgroundThe relationship between pneumococcal conjugate vaccine–induced antibody responses and protection against community-acquired pneumonia (CAP) and acute otitis media (AOM) is unclear. This study assessed the impact of the ten-valent pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on these end points. The primary objective was to demonstrate vaccine efficacy (VE) in a per-protocol analysis against likely bacterial CAP (B-CAP: radiologically confirmed CAP with alveolar consolidation/pleural effusion on chest X-ray, or non-alveolar infiltrates and C-reactive protein ≥ 40 µg/ml); other protocol-specified outcomes were also assessed.ConclusionsEfficacy was demonstrated against a broad range of pneumococcal diseases commonly encountered in young children in clinical practice.

Trial registration

www.ClinicalTrials.gov NCT00466947Please see later in the article for the Editors'' Summary
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号